Clinical Trial: Strategy to Adapt Botulinum Toxin Doses in Dystonia

U.S., April 26 -- ClinicalTrials.gov registry received information related to the study (NCT06386848) titled 'Strategy to Adapt Botulinum Toxin Doses in Dystonia' on Jan. 18.

Brief Summary: The study is designed to observ and collect the doses of botulinum toxin injected in dystonia in different centres to compare the initial dose and the dose recommended.

We we ll study the increase of the dose injected over the time, the side effects...

The hypothesis is that we inject smaller doses than we could regarding the recommandations

Study Type: Observational

Condition: Dystonia

Intervention: Drug: Botulinum toxin

Botulinum toxin doses injected in dystonia

Other Name: onabotulinumtoxinA, abobotulinumtoxinA, incobotulinumtoxinA

Recruitmen...